News | February 24, 2009

Researchers Work on PET with IMRT for "Dose Painting"

February 24, 2009 - Researchers are testing the use of positron emission tomography (PET) for dose painting, but have found the technique is limited by PET’s spatial resolution, according to researchers from the Catholic University of Louvain, Brussels, Belgium (Radiother. Oncol. doi: 10.1016/j.radonc.2008.11.014).

The theory is to use PET with a radiotherapy plan that takes account of tumor physiology, and to use PET to "paint" the dose to regions of intense activity or radiation resistance. PET is used in combination with intensity-modulated radiotherapy (IMRT) with an appropriate functional imaging modality.

The use of PET for dose painting relies on a perfect correlation between the observed PET signal and the underlying biology of interest. To test this, Nicolas Christian and colleagues imaged 15 tumor-bearing mice with PET following injection of the radiotracer 2-fluoro-2-deoxyglucose (18F-FDG). The mice were also imaged with MRI and then assessed using autoradiography.

The PET and autoradiography images however did not always match, particularly in tumor sub-volumes with high 18F-FDG-activity. This mismatch is significant because a biological image-guided IMRT plan would most likely increase the dose to these sites. The larger the tumor volume and the lower the activity threshold, then the better the match.

"Unfortunately, we do not yet have access to spatial image resolution that is good enough to be able to visualize what is going on at the microscopic level. We may make fairly large mistakes in the dose distribution by relying on what we see on the PET," said Vincent Grégoire, professor in radiation oncology at the Catholic University of Louvain and corresponding author for the paper.

Grégoire noted that if a PET system with a higher resolution were developed, the technique may be viable. The researchers are instead examining whether alternative radioisotope tracers could provide a better way of finding specific sites in the tumor where the dose should be increased, such as clusters of hypoxic cells. The researchers still want to investigate the concept of PET-based dose painting.

Source: Medical Physics Web

For more information: medicalphysicsweb.org

Related Content

International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...
BGN Technologies Introduces Novel Medical Imaging Radioisotope Production Method
News | Radiopharmaceuticals and Tracers | June 05, 2019
BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), introduced a novel method for...
RefleXion Opens New Manufacturing Facility for Biology-guided Radiotherapy Platform
News | Radiation Therapy | May 31, 2019
RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters in Hayward,...
Study Explores Magnetic Nanoparticles as Bimodal Imaging Agent for PET/MRI

Image courtesy of MR Solutions.

News | PET-MRI | May 23, 2019
Researchers from Bourgogne University in Dijon, France, showed that use of superparamagnetic iron oxide nanoparticles (...
New Phase 2B Trial Exploring Target-Specific Myocardial Ischemia Imaging Agent
News | Radiopharmaceuticals and Tracers | May 17, 2019
Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in...
Blue Earth Diagnostics Expands Access to Axumin in Europe
News | Radiopharmaceuticals and Tracers | May 13, 2019
Blue Earth Diagnostics announced expanded access to the Axumin (fluciclovine (18F)) imaging agent in Europe. The first...
Accuray Launches Synchrony Motion Tracking and Correction Technology for Radixact System
Technology | Image Guided Radiation Therapy (IGRT) | April 24, 2019
Accuray announced the launch of its Synchrony motion tracking and correction technology to be used with the Radixact...
NIH Study of Brain Energy Patterns Provides New Insights into Alcohol Effects

NIH scientists present a new method for combining measures of brain activity (left) and glucose consumption (right) to study regional specialization and to better understand the effects of alcohol on the human brain. Image courtesy of Ehsan Shokri-Kojori, Ph.D., of NIAAA.

News | Neuro Imaging | March 22, 2019
March 22, 2019 — Assessing the patterns of energy use and neuronal activity simultaneously in the human brain improve